TSPO has been used as a biomarker of brain injury and inflammation in various neurological diseases, including dementia [5, 6], degenerative diseases [7–9], multiple sclerosis [10, 11], encephalitis [12, 13], and stroke [14–17]. This evidence concerns the gene TSPO and Stroke.